18702 N. CREEK PARKWAY, BOTHELL, WA
Immunome, Inc. 2026 Annual Meeting Results; Directors Elected
Reports First Quarter 2026 Financial Results and Provides Business Update
Annual Report to Security Holders
Reports Full Year 2025 Financial Results and Provides Business Update
Announces Pricing of Public Offering of Common Stock
Investor Presentation
Reports Third Quarter 2025 Financial Results and Provides Business Update
Financial Results, Press Release
Q1
FY 2025
Q3
Q2
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities